Study: Too many seniors are back in hospital for infections treated during initial stay

The most common type of pre-existing infection in the patients was C. difficile


The rate of hospital readmissions for seniors with infections that were first treated during their initial hospital stay is too high, according to new research.

As many as 5 percent of patients leaving the hospital with an infection have a readmission for that pre-existing infection, according to an article on the U.S. News website.

A team analyzed Medicare data on more than 318,000 hospital discharges for patients aged 65 and older. Overall, 2.5% of them were readmitted for a pre-existing infection.

The most common type of pre-existing infection in the patients was C. difficile (about a 5% readmission rate) followed by urinary tract infections (2.4% readmission rate).

Read the article.

 



November 5, 2019


Topic Area: Infection Control


Recent Posts

AI Usage for Healthcare Facilities

People in all industries are finding more use cases for artificial intelligence.


Ground Broken on Pelican Valley Senior Living Modernization Project

It is expected to reach completion in early-mid 2027.


All-Electric UCI Health – Irvine Hospital Set to Open

The 144-bed facility will be the nation’s first all-electric acute care hospital, serving the residents of coastal and south Orange County.


The Rising Strategic Value of Owner's Reps in Healthcare

The role of the owner’s representative has evolved beyond project advocate to strategic campus planning consultant.


Lawrence Group Designs Pair of Ignite Medical Resorts in Missouri

They combine cutting-edge physical rehabilitation with the indulgence of a 5-Star hotel.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.